329 related articles for article (PubMed ID: 24336058)
1. Systematic review of the indirect effect of pneumococcal conjugate vaccine dosing schedules on pneumococcal disease and colonization.
Loo JD; Conklin L; Fleming-Dutra KE; Knoll MD; Park DE; Kirk J; Goldblatt D; O'Brien KL; Whitney CG
Pediatr Infect Dis J; 2014 Jan; 33 Suppl 2(Suppl 2 Optimum Dosing of Pneumococcal Conjugate Vaccine For Infants 0 A Landscape Analysis of Evidence Supportin g Different Schedules):S161-71. PubMed ID: 24336058
[TBL] [Abstract][Full Text] [Related]
2. Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on vaccine-type nasopharyngeal carriage.
Fleming-Dutra KE; Conklin L; Loo JD; Knoll MD; Park DE; Kirk J; Goldblatt D; Whitney CG; O'Brien KL
Pediatr Infect Dis J; 2014 Jan; 33 Suppl 2(Suppl 2 Optimum Dosing of Pneumococcal Conjugate Vaccine For Infants 0 A Landscape Analysis of Evidence Supportin g Different Schedules):S152-60. PubMed ID: 24336057
[TBL] [Abstract][Full Text] [Related]
3. Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on vaccine-type invasive pneumococcal disease among young children.
Conklin L; Loo JD; Kirk J; Fleming-Dutra KE; Deloria Knoll M; Park DE; Goldblatt D; O'Brien KL; Whitney CG
Pediatr Infect Dis J; 2014 Jan; 33 Suppl 2(Suppl 2 Optimum Dosing of Pneumococcal Conjugate Vaccine For Infants 0 A Landscape Analysis of Evidence Supportin g Different Schedules):S109-18. PubMed ID: 24336053
[TBL] [Abstract][Full Text] [Related]
4. Impact of pneumococcal conjugate vaccines on nasopharyngeal carriage and invasive disease among unvaccinated people: review of evidence on indirect effects.
Davis SM; Deloria-Knoll M; Kassa HT; O'Brien KL
Vaccine; 2013 Dec; 32(1):133-45. PubMed ID: 23684824
[TBL] [Abstract][Full Text] [Related]
5. Long-term Impact of a "3 + 0" Schedule for 7- and 13-Valent Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease in Australia, 2002-2014.
Jayasinghe S; Menzies R; Chiu C; Toms C; Blyth CC; Krause V; McIntyre P
Clin Infect Dis; 2017 Jan; 64(2):175-183. PubMed ID: 27986682
[TBL] [Abstract][Full Text] [Related]
6. Imputing the Direct and Indirect Effectiveness of Childhood Pneumococcal Conjugate Vaccine Against Invasive Pneumococcal Disease by Surveying Temporal Changes in Nasopharyngeal Pneumococcal Colonization.
Nzenze SA; Madhi SA; Shiri T; Klugman KP; de Gouveia L; Moore DP; Karstaedt AS; Tempia S; Nunes MC; von Gottberg A
Am J Epidemiol; 2017 Aug; 186(4):435-444. PubMed ID: 28482004
[TBL] [Abstract][Full Text] [Related]
7. Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway.
Steens A; Bergsaker MA; Aaberge IS; Rønning K; Vestrheim DF
Vaccine; 2013 Dec; 31(52):6232-8. PubMed ID: 24176490
[TBL] [Abstract][Full Text] [Related]
8. Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on prevention of pneumonia.
Loo JD; Conklin L; Fleming-Dutra KE; Deloria Knoll M; Park DE; Kirk J; Goldblatt D; O'Brien KL; Whitney CG
Pediatr Infect Dis J; 2014 Jan; 33 Suppl 2(Suppl 2 Optimum Dosing of Pneumococcal Conjugate Vaccine For Infants 0 A Landscape Analysis of Evidence Supportin g Different Schedules):S140-51. PubMed ID: 24336056
[TBL] [Abstract][Full Text] [Related]
9. The impact of pneumococcal conjugate vaccines on serotype 19A nasopharyngeal carriage.
Tin Tin Htar M; Sings HL; Syrochkina M; Taysi B; Hilton B; Schmitt HJ; Gessner BD; Jodar L
Expert Rev Vaccines; 2019 Dec; 18(12):1243-1270. PubMed ID: 31587592
[No Abstract] [Full Text] [Related]
10. Effect of reduced-dose schedules with 7-valent pneumococcal conjugate vaccine on nasopharyngeal pneumococcal carriage in children: a randomized controlled trial.
van Gils EJ; Veenhoven RH; Hak E; Rodenburg GD; Bogaert D; Ijzerman EP; Bruin JP; van Alphen L; Sanders EA
JAMA; 2009 Jul; 302(2):159-67. PubMed ID: 19584345
[TBL] [Abstract][Full Text] [Related]
11. Pneumococcal nasopharyngeal carriage following reduced doses of a 7-valent pneumococcal conjugate vaccine and a 23-valent pneumococcal polysaccharide vaccine booster.
Russell FM; Carapetis JR; Satzke C; Tikoduadua L; Waqatakirewa L; Chandra R; Seduadua A; Oftadeh S; Cheung YB; Gilbert GL; Mulholland EK
Clin Vaccine Immunol; 2010 Dec; 17(12):1970-6. PubMed ID: 20943882
[TBL] [Abstract][Full Text] [Related]
12. Effect of age and vaccination with a pneumococcal conjugate vaccine on the density of pneumococcal nasopharyngeal carriage.
Roca A; Bottomley C; Hill PC; Bojang A; Egere U; Antonio M; Darboe O; Greenwood BM; Adegbola RA
Clin Infect Dis; 2012 Sep; 55(6):816-24. PubMed ID: 22700830
[TBL] [Abstract][Full Text] [Related]
13. Impact of Pneumococcal Conjugate Vaccine Administration in Pediatric Older Age Groups in Low and Middle Income Countries: A Systematic Review.
Bonner K; Welch E; Elder K; Cohn J
PLoS One; 2015; 10(8):e0135270. PubMed ID: 26332848
[TBL] [Abstract][Full Text] [Related]
14. The herd effects of infant PCV7/PCV13 sequential implementation on adult invasive pneumococcal disease, six years post implementation; a nationwide study in Israel.
Regev-Yochay G; Katzir M; Strahilevitz J; Rahav G; Finn T; Miron D; Maor Y; Chazan B; Schindler Y; Dagan R;
Vaccine; 2017 Apr; 35(18):2449-2456. PubMed ID: 28342668
[TBL] [Abstract][Full Text] [Related]
15. The rise and fall of pneumococcal serotypes carried in the PCV era.
Devine VT; Cleary DW; Jefferies JM; Anderson R; Morris DE; Tuck AC; Gladstone RA; O'Doherty G; Kuruparan P; Bentley SD; Faust SN; Clarke SC
Vaccine; 2017 Mar; 35(9):1293-1298. PubMed ID: 28161425
[TBL] [Abstract][Full Text] [Related]
16. Pneumococcal carriage and invasive disease in children before introduction of the 13-valent conjugate vaccine: comparison with the era before 7-valent conjugate vaccine.
Sharma D; Baughman W; Holst A; Thomas S; Jackson D; da Gloria Carvalho M; Beall B; Satola S; Jerris R; Jain S; Farley MM; Nuorti JP
Pediatr Infect Dis J; 2013 Feb; 32(2):e45-53. PubMed ID: 23080290
[TBL] [Abstract][Full Text] [Related]
17. The potential impact of pneumococcal conjugate vaccine in Africa: Considerations and early lessons learned from the South African experience.
Madhi SA; Nunes MC
Hum Vaccin Immunother; 2016; 12(2):314-25. PubMed ID: 26317537
[TBL] [Abstract][Full Text] [Related]
18. Early Declines in Vaccine Type Pneumococcal Carriage in Children Less Than 5 Years Old After Introduction of 10-valent Pneumococcal Conjugate Vaccine in Mozambique.
Sigaúque B; Moiane B; Massora S; Pimenta F; Verani JR; Mucavele H; Chaúque A; Quintó L; Dos Santos RT; Carvalho MDG; Whitney CG; Lessa FC
Pediatr Infect Dis J; 2018 Oct; 37(10):1054-1060. PubMed ID: 30216295
[TBL] [Abstract][Full Text] [Related]
19. Dose-specific Effectiveness of 7- and 13-Valent Pneumococcal Conjugate Vaccines Against Vaccine-serotype Streptococcus pneumoniae Colonization in Children.
Lewnard JA; Givon-Lavi N; Dagan R
Clin Infect Dis; 2020 Nov; 71(8):e289-e300. PubMed ID: 31784753
[TBL] [Abstract][Full Text] [Related]
20. Colonization with 19F and other pneumococcal conjugate vaccine serotypes in children in St. Louis, Missouri, USA.
McFarland M; Szasz TP; Zhou JY; Motley K; Sivapalan JS; Isaacson-Schmid M; Todd EM; Hogan PG; Fritz SA; Burnham CD; Hoffmann S; Morley SC
Vaccine; 2017 Aug; 35(34):4389-4395. PubMed ID: 28687405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
